Capso Vision
Open enrollment across a mixed-phase pipeline
According to ClinicalTrials.gov-derived indexes, Capso Vision sits in the upper quartile of US sponsors by registered trial count (#2,085 of 15,742 sponsors by registered trial count).
Capso Vision: 6 sponsored US clinical trials, 1 recruiting.
Capso Vision sponsors 6 registered US clinical trials on ClinicalTrials.gov, 1 of them currently recruiting, and 5 completed. The most-studied condition in this pipeline is Colonic Polyps, with 2 trials.
Upper-quartile sponsor footprint
Capso Vision sits in the upper quartile of the sponsor corpus (#2,085 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Open and recent trials
6 total, page 1 of 1
Prospective, Open-label, Non-significant Risk, Multicenter Study Comparing the Polyp Detection of the Study Device to That of the Colonoscopy Reference
NCT07089615
Data Collection for CV-3E AI Software Development
NCT06916845
Pivotal Study of the CapsoCam Colon (CV-3) in Detecting Colonic Polyps, Using Colonoscopy as the Reference
NCT04607746
CapsoCam® Colon Capsule Endoscope (CCE) Compared to Colonoscopy (OC)
NCT04246632
Validation of CapsoVision CapsoCam® SV-3 Capsule Endoscopy System
NCT04573959
Comparison of Capso Vision SV-1 to PillCam SB2 in the Evaluation of Subjects With Suspected Small Bowel Disease
NCT01787825
Therapeutic Areas
What is open in the Capso Vision pipeline
1 recruiting of 6 indexed (17% open); 5 completed (83%).
Phase labels are sparse on this sponsor index, so phase mix is not charted here.
Top condition: Colonic Polyps (2 trials), 6 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Capso Vision: open-pipeline peers nationwide
Peers matched on 6 registered trials and 17% open enrollment, not the therapeutic-area sidebar.
Capso Vision sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 6 trials (± recruiting share)
- 23andMe · 6 trials · 0% recruiting
- Aardvark Therapeutics · 6 trials · 0% recruiting
- Abbisko Therapeutics Co · 6 trials · 67% recruiting
- AbGenomics B.V Taiwan Branch · 6 trials · 0% recruiting
Sponsors near 17% open enrollment (± trial volume)
- Adagene · 17% recruiting · 6 trials
- Agendia · 17% recruiting · 6 trials
- Akamis Bio · 17% recruiting · 6 trials
- Angiodynamics · 17% recruiting · 12 trials
Related
What to do with this Capso Vision page
6 registered trials is a research-attention snapshot, not an endorsement of Capso Vision or any single study.
- 1 of Capso Vision's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Colonic Polyps is the condition Capso Vision studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Colonic Polyps trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Capso Vision pipeline card: 6 registered trials from official public datasets.Report a data error.